The Drug Rediscovery Protocol (DRUP Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Palbociclib
Related studies linked through entity extraction aliases.
PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- Status
- RECRUITING
- Phase
- PHASE2
Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant
- Status
- COMPLETED
- Phase
- PHASE2
Palbociclib With Everolimus + Exemestane In BC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Trial to Assess the Activity and Safety of Palbociclib in Patients With Well and Moderately Differentiated Metastatic Pancreatic Neuroendocrine Tumors (pNET)
- Status
- COMPLETED
- Phase
- PHASE2
Palbociclib and FES PET
- Status
- COMPLETED
- Phase
- PHASE2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis
- Status
- TERMINATED
- Phase
- PHASE2
Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE4